Skip to main content
Top
Published in: Supportive Care in Cancer 7/2005

01-07-2005 | Short Communication

The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT—results of a randomized multicentre study

Authors: Samuel Vokurka, Eva Bystřická, Vladimír Koza, Jana Sčudlová, Vladislava Pavlicová, Dana Valentová, Jana Bocková, Lubica Mišaniová

Published in: Supportive Care in Cancer | Issue 7/2005

Login to get access

Abstract

Antimicrobial solutions are widely used in the nursing care of chemotherapy induced oral mucositis (OM). There is little evidence, however, supporting their use for reducing mucosal damage. In our study, 132 patients were randomized to use normal saline (n=65) or povidone-iodine diluted 1:100 (n=67) mouthwashes for OM prophylaxis and treatment after high-dose chemotherapy comprising BEAM or HD-L-PAM followed by autologous peripheral stem cell transplantation. The study groups were well balanced in respect of age, sex, chemotherapy and the number of CD34+ cells in the graft. No significant difference was found between the groups in respect of OM characteristics, fever of unknown origin (FUO) and other infections. The antimicrobial solution was less tolerable for patients. OM occurred significantly more often in females than in males (86% vs 60%, P=0.0016) and was worse and of longer duration. The mechanical effect of mouthwashes might have a certain importance in FUO prevention. When indicating oral rinses, the patient’s individual preference and tolerance of solutions offered should be considered.
Literature
1.
go back to reference Sonis S, Oster G, Fuchs H, et al (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19:2201–2205PubMed Sonis S, Oster G, Fuchs H, et al (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19:2201–2205PubMed
2.
go back to reference Sezer O, Eucker J, Metzner B, et al (2000) Mucositis is associated with increased rate of documented infections and treatment related mortality after high-dose therapy with autologous peripheral stem-cell transplantation. Proc ASCO (abstract 216.) Sezer O, Eucker J, Metzner B, et al (2000) Mucositis is associated with increased rate of documented infections and treatment related mortality after high-dose therapy with autologous peripheral stem-cell transplantation. Proc ASCO (abstract 216.)
3.
go back to reference Donnelly P, Bellm L, Epstein J, Sonis S, Symonds P (2003) Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infect Dis 7:405–412 Donnelly P, Bellm L, Epstein J, Sonis S, Symonds P (2003) Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infect Dis 7:405–412
4.
go back to reference Ferreti GA, Raybould TP, Brown AT, et al (1990) Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomised double-blind trial. Oral Surg Oral Med Oral Pathol 69:331–338 Ferreti GA, Raybould TP, Brown AT, et al (1990) Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomised double-blind trial. Oral Surg Oral Med Oral Pathol 69:331–338
5.
go back to reference Weisdorf DJ, Bostrom B, Raether D, et al (1989) Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse. Bone Marrow Transplant 4:89–95 Weisdorf DJ, Bostrom B, Raether D, et al (1989) Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse. Bone Marrow Transplant 4:89–95
6.
go back to reference Dodd MJ, Larson PJ, Dibble SL, et al (1996) Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncol Nurs Forum 23:921–927 Dodd MJ, Larson PJ, Dibble SL, et al (1996) Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncol Nurs Forum 23:921–927
7.
go back to reference Samaranayake LP, Robertson AG, MacFarlane TW, et al (1988) The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation. Clin Radiol 39:291–294 Samaranayake LP, Robertson AG, MacFarlane TW, et al (1988) The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation. Clin Radiol 39:291–294
8.
go back to reference Lever SA, Dupuis LL, Chan HS (1987) Comparative evaluation of benzydamine oral rinse in children with antineoplastic-induced stomatitis. Drug Intel Clin Pharm 21:359–361 Lever SA, Dupuis LL, Chan HS (1987) Comparative evaluation of benzydamine oral rinse in children with antineoplastic-induced stomatitis. Drug Intel Clin Pharm 21:359–361
9.
go back to reference Prada A, Chisea E (1987) Effects of benzydamine on the oral mucositis during antineoplastic radiotherapy and/or intra-arterial chemotherapy. Int J Tissue React 9:115–119 Prada A, Chisea E (1987) Effects of benzydamine on the oral mucositis during antineoplastic radiotherapy and/or intra-arterial chemotherapy. Int J Tissue React 9:115–119
10.
go back to reference Rahn R, Adamietz IA, Boettcher HD, Schaefer V, Reimer K, Fleischer W (1997) Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy. Dermatology 195 [Suppl 2]:57–61 Rahn R, Adamietz IA, Boettcher HD, Schaefer V, Reimer K, Fleischer W (1997) Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy. Dermatology 195 [Suppl 2]:57–61
11.
go back to reference Allison RR, Vongtama V, Vaughan J, Shin KH (1995) Symptomatic acute mucositis can be minimized or prophylaxed by the combination of sucralfate and fluconazole. Cancer Invest 13:16–22 Allison RR, Vongtama V, Vaughan J, Shin KH (1995) Symptomatic acute mucositis can be minimized or prophylaxed by the combination of sucralfate and fluconazole. Cancer Invest 13:16–22
12.
go back to reference Okuno SH, Foote RL, Loprinzi CL, et al (1997) A randomized trial of nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis. Cancer 79:2193–2199 Okuno SH, Foote RL, Loprinzi CL, et al (1997) A randomized trial of nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis. Cancer 79:2193–2199
13.
go back to reference Wijers OB, Levendag PC, Harms ER, et al (2001) Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study. Int J Radiat Oncol Biol Phys 50:343–352 Wijers OB, Levendag PC, Harms ER, et al (2001) Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study. Int J Radiat Oncol Biol Phys 50:343–352
14.
go back to reference Karthaus M, Rosental C, Ganser A (1999) Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis—are there new strategies? Bone Marrow Transplant 24:1095–1108 Karthaus M, Rosental C, Ganser A (1999) Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis—are there new strategies? Bone Marrow Transplant 24:1095–1108
15.
go back to reference Sonis S, Elting L, Keefe D, et al (2004) Perspectives on cancer therapy-induced mucosal injury. Cancer 100 [9 Suppl]:1995–2025 Sonis S, Elting L, Keefe D, et al (2004) Perspectives on cancer therapy-induced mucosal injury. Cancer 100 [9 Suppl]:1995–2025
16.
go back to reference Robien K, Schubert M, Bruemmer B, et al (2004) Predictors of oral mucositis in patients receiving hematopoietic cell transplant for chronic myelogenous leukemia. J Clin Oncol 22:1268–1275 Robien K, Schubert M, Bruemmer B, et al (2004) Predictors of oral mucositis in patients receiving hematopoietic cell transplant for chronic myelogenous leukemia. J Clin Oncol 22:1268–1275
Metadata
Title
The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT—results of a randomized multicentre study
Authors
Samuel Vokurka
Eva Bystřická
Vladimír Koza
Jana Sčudlová
Vladislava Pavlicová
Dana Valentová
Jana Bocková
Lubica Mišaniová
Publication date
01-07-2005
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 7/2005
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-005-0792-9

Other articles of this Issue 7/2005

Supportive Care in Cancer 7/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine